Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01553539 · OUTCOME

Plasma Levels of Angiogenic Peptides Including Placental Growth Factor (PlGF)

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery · Source last updated 2018-07-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
pg/mL
Interval / dispersion
Standard Deviation
Time frame
Baseline and Day 22

Groups in this outcome

Treatment (Antiangiogenesis Therapy)

Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Antiangiogenesis Therapy)20

Reported measurements

Ang-(1-7) Baseline
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)18.4385.0Not reportedNot reportedNot reported
Ang-(1-7) Day 22
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)41.22840.0Not reportedNot reportedNot reported
Ang II Baseline
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)21.311.5Not reportedNot reportedNot reported
Ang II Day 22
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)31.526.5Not reportedNot reportedNot reported
Ang I Baseline
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)22.5127Not reportedNot reportedNot reported
Ang I Day 22
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)17.552.7Not reportedNot reportedNot reported
VEGF Baseline
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)65.666.4Not reportedNot reportedNot reported
VEGF Day 22
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)49.643.0Not reportedNot reportedNot reported
PIGF Baseline
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)4.32.1Not reportedNot reportedNot reported
PIGF Day 22
Values in pg/mL · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Treatment (Antiangiogenesis Therapy)3.01.7Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        385.0
        value
        18.4
    title
    Ang-(1-7) Baseline
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        2840.0
        value
        41.2
    title
    Ang-(1-7) Day 22
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.5
        value
        21.3
    title
    Ang II Baseline
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        26.5
        value
        31.5
    title
    Ang II Day 22
  5. categories
    1. measurements
      1. group Id
        OG000
        spread
        127
        value
        22.5
    title
    Ang I Baseline
  6. categories
    1. measurements
      1. group Id
        OG000
        spread
        52.7
        value
        17.5
    title
    Ang I Day 22
  7. categories
    1. measurements
      1. group Id
        OG000
        spread
        66.4
        value
        65.6
    title
    VEGF Baseline
  8. categories
    1. measurements
      1. group Id
        OG000
        spread
        43.0
        value
        49.6
    title
    VEGF Day 22
  9. categories
    1. measurements
      1. group Id
        OG000
        spread
        2.1
        value
        4.3
    title
    PIGF Baseline
  10. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.7
        value
        3.0
    title
    PIGF Day 22
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
dispersion Type
Standard Deviation
groups
  1. description
    Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.
    id
    OG000
    title
    Treatment (Antiangiogenesis Therapy)
param Type
MEDIAN
reporting Status
POSTED
time Frame
Baseline and Day 22
title
Plasma Levels of Angiogenic Peptides Including Placental Growth Factor (PlGF)
type
SECONDARY
unit Of Measure
pg/mL

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice